QKI has long been associated with neurological diseases and cancers, modulating various pathways through both transcriptional and post-transcriptional regulation (Ebersole et al., 1996; Feng and Bankston, 2010; Darbelli and Richard, 2016). Here, QKI is linked to nervous system disorder.